What Is the Cost of Multiple Myeloma Treatment in Germany?
The cost of Multiple Myeloma treatment in Germany typically ranges from $18,000 to $70,000 USD, depending on the hospital, city, and type of procedure.
Multiple myeloma is a cancer of plasma cells in the bone marrow. Abnormal plasma cells can form tumours in many bones and produce an abnormal protein (M protein). In Germany, the total depends on:
- Induction treatment: combinations such as bortezomib, lenalidomide, daratumumab and dexamethasone.
- High-dose chemotherapy with stem cell transplant: for suitable patients.
- Maintenance treatment: such as lenalidomide.
- Bone protection and supportive care: bisphosphonates, denosumab and radiotherapy.
Cancer treatment costs depend on the stage and the treatments needed. A full course of care can cost more than this range, so ask what each estimate includes.
Myeloma Symptoms and Tests
The US National Cancer Institute (NCI) explains that myeloma can cause bone pain in the back or ribs, fractures, infections, tiredness and high calcium levels. M protein can thicken the blood and damage the kidneys.
Tests include blood and urine tests for M protein and free light chains, beta-2-microglobulin, a bone marrow biopsy and imaging such as MRI or PET-CT. People without symptoms may be watched rather than treated straight away.
Our Services for Multiple Myeloma Treatment in Germany
Transparent, professional support—without the hassles.
Book Doctor Appointment
Choose a specialist and schedule a convenient consultation.
Video or In-person Consultation
Consult remotely or meet your doctor directly at the hospital.
Compare Cost Estimates
Review transparent estimates from suitable hospitals.
Hospitalisation Support
Get coordinated assistance throughout your hospital stay.
Myeloma Treatment Steps
Initial (induction) treatment often combines medicines such as bortezomib, daratumumab, lenalidomide and dexamethasone. Suitable patients then have high-dose chemotherapy with a transplant of their own stem cells, followed by maintenance treatment such as lenalidomide.
Bisphosphonates or denosumab strengthen bones, radiotherapy treats painful bone lesions, and plasmapheresis removes thick blood proteins. Further options are used if myeloma returns, and CAR T-cell therapy is being studied in trials.
Myeloma Treatment in Germany
Myeloma treatment happens in phases, and a stem cell transplant involves a hospital stay of several weeks. German hospitals usually estimate each phase separately. International patients are usually treated in Germany as self-paying patients: the hospital reviews the medical reports, sends a cost estimate and asks for an advance payment before admission, then settles the final bill after discharge.
Maintenance tablets may continue for a long time, so ask how they would be supplied after you return home.
Top Doctors in Germany
Recommended Doctors for Multiple Myeloma Treatment
Top Hospitals in Germany
Recommended Hospitals for Multiple Myeloma Treatment
Frequently Asked Questions Related to Multiple Myeloma Treatment Cost in Germany
Multiple myeloma is a cancer of plasma cells in the bone marrow. The abnormal cells can damage bones and produce an abnormal protein.
The NCI lists bone pain in the back or ribs, fractures, infections, tiredness and high calcium levels. Some people have no symptoms when it is found.
Blood and urine tests look for M protein and free light chains, and a bone marrow biopsy confirms the diagnosis. Imaging checks the bones.
Not always, as people without symptoms may be watched closely. Treatment starts when symptoms or organ damage appear.
Induction is the first phase of treatment, often combining medicines such as bortezomib, lenalidomide, daratumumab and dexamethasone. It aims to bring the myeloma under control.
A transplant of the person's own stem cells allows very high-dose chemotherapy to be given. It can lengthen the time before myeloma returns.
The cost of Multiple Myeloma treatment in Germany typically ranges from $18,000 to $70,000 USD, depending on the hospital, city, and type of procedure.
Maintenance is ongoing treatment, often lenalidomide, after the main treatment. It aims to keep the myeloma under control for longer.
Bisphosphonates or denosumab strengthen bones, and radiotherapy can treat painful bone lesions. These lower the risk of fractures.
An autologous stem cell transplant usually means a hospital stay of several weeks plus time for collection and recovery. Ask the hospital for an expected timeline.




























